Is shared decision-making a determinant of polypharmacy in older patients with chronic disease? A cross-sectional study in Hubei Province, China

[1] Zhou M(2019)Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet 394 1145-1158

[2] Wang H(2015)Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review BMJ Open 5 86-88

[3] Zeng X(2009)The effects of polypharmacy in older adults Clin Pharmacol Ther 85 503-511

[4] Yin P(2021)International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study Nephrol Dial Transplant 36 230-204

[5] Zhu J(2019)Prevalence and predictors of polypharmacy prescription among type 2 diabetes patients at a tertiary care department in Ningbo, China: A retrospective database study PLoS ONE 14 1728-1296

[6] Chen W(2017)What is polypharmacy? A systematic review of definitions BMC Geriatr 17 196-661

[7] Li X(2017)Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study JAMA 7 1295-38

[8] Wang L(2014)Shared decision-making for older adults with cardiovascular disease PLoS ONE 9 651-1332

[9] Wang L(2020)The connection between evidence-based medicine and shared decision making Clin Cardiol 43 109-267

[10] Liu Y(2014)Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model JAMA 312 32-288

[1] Zhou M(2019)Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Lancet 394 1145-1158

[2] Wang H(2015)Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review BMJ Open 5 86-88

[3] Zeng X(2009)The effects of polypharmacy in older adults Clin Pharmacol Ther 85 503-511

[4] Yin P(2021)International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study Nephrol Dial Transplant 36 230-204

[5] Zhu J(2019)Prevalence and predictors of polypharmacy prescription among type 2 diabetes patients at a tertiary care department in Ningbo, China: A retrospective database study PLoS ONE 14 1728-1296

[6] Chen W(2017)What is polypharmacy? A systematic review of definitions BMC Geriatr 17 196-661

[7] Li X(2017)Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study JAMA 7 1295-38

[8] Wang L(2014)Shared decision-making for older adults with cardiovascular disease PLoS ONE 9 651-1332

[9] Wang L(2020)The connection between evidence-based medicine and shared decision making Clin Cardiol 43 109-267

[10] Liu Y(2014)Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model JAMA 312 32-288